Sarepta Therapeutics, Inc. (SRPT): Among the Stocks That Will Go to The Moon According to Analysts
We recently compiled a list of the 15 Stocks That Will Go to The Moon According to Analysts. In this article, we are going to ...
Sarepta Therapeutics (SRPT) To Report Earnings Tomorrow: Here Is What To Expect
Biotech company Sarepta Therapeutics (NASDAQ:SRPT) will be reporting results tomorrow after the bell. Here’s what you need to ...
Sarepta Therapeutics (SRPT) Gets a Buy from Evercore ISI
In a report released yesterday, Gavin Clark-Gartner from Evercore ISI maintained a Buy rating on Sarepta Therapeutics (SRPT – Research Report), ...
Apellis Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference
Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will present at the TD Cowen 45 th Annual Health Care Conference on Monday, March 3, 2025, at 10:30 a.m. ET. The live ...
PPL Co. (NYSE:PPL) Receives Consensus Rating of “Moderate Buy” from Analysts
PPL Co. (NYSE:PPL – Get Free Report) has earned a consensus rating of “Moderate Buy” from the eleven brokerages that are ...
kalkinemedia5d
How Is Sarepta Therapeutics (NASDAQ:SRPT) Advancing in the Biopharmaceutical Sector?
Highlights,Sarepta Therapeutics continues to expand its RNA-targeted and gene therapy treatments for rare ...
15 Best Fast Growth Stocks To Buy Right Now
In the fourth quarter of 2024, the US Gross Domestic Product (GDP) expanded at an annual rate of 2.3%, slightly below market ...
Arrowhead Pharmaceuticals: Progress During Adverse Market Conditions
Arrowhead Pharmaceuticals stock could remain under pressure in the near-term, but improved financial outlook and pipeline ...
Hosted on MSN6d
Solid Biosciences Soars 32% on Trial Data: 189% Upside from Here?
Shares of biotech company Solid Biosciences (NASDAQ: SLDB) skyrocketed on Feb. 18 after the firm released key clinical data.